Multisite Evaluation and Validation of Optical Genome Mapping for Prenatal Genetic Testing. Read more about Multisite Evaluation and Validation of Optical Genome Mapping for Prenatal Genetic Testing.
A Novel Integrated Approach for Cytogenomic Evaluation of Plasma Cell Neoplasms. Read more about A Novel Integrated Approach for Cytogenomic Evaluation of Plasma Cell Neoplasms.
Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic Profiling. Read more about Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma with Comprehensive Genomic Profiling.
Identifying End Users' Preferences about Structuring Pharmacogenetic Test Orders in an Electronic Health Record System. Read more about Identifying End Users' Preferences about Structuring Pharmacogenetic Test Orders in an Electronic Health Record System.
MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology. Read more about MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology.
Software-Assisted Manual Review of Clinical Next-Generation Sequencing Data: An Alternative to Routine Sanger Sequencing Confirmation with Equivalent Results in >15,000 Germline DNA Screens. Read more about Software-Assisted Manual Review of Clinical Next-Generation Sequencing Data: An Alternative to Routine Sanger Sequencing Confirmation with Equivalent Results in >15,000 Germline DNA Screens.
Evaluation for Genetic Disorders in the Absence of a Clinical Indication for Testing: Elective Genomic Testing. Read more about Evaluation for Genetic Disorders in the Absence of a Clinical Indication for Testing: Elective Genomic Testing.
Next-Generation Sequencing for Lymphomas: Perfecting a Pipeline for Personalized Pathobiologic and Prognostic Predictions. Read more about Next-Generation Sequencing for Lymphomas: Perfecting a Pipeline for Personalized Pathobiologic and Prognostic Predictions.
Health Care Infrastructure for Financially Sustainable Clinical Genomics. Read more about Health Care Infrastructure for Financially Sustainable Clinical Genomics.
Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens. Read more about Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens.
